Theratechnologies
THTX
THTX was delisted on the 25th of September, 2025.
41 hedge funds and large institutions have $25.2M invested in Theratechnologies in 2024 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 10 increasing their positions, 7 reducing their positions, and 3 closing their positions.
167% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 3
43% more repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 7
40% more capital invested
Capital invested by funds: $18M → $25.2M (+$7.16M)
14% more funds holding
Funds holding: 36 → 41 (+5)
1.38% less ownership
Funds ownership: 31.65% → 30.27% (-1.4%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$81.4K |
| 2 |
HIM
Hillsdale Investment Management
Toronto,
Ontario, Canada
|
+$81K |
| 3 |
MCM
MAI Capital Management
Independence,
Ohio
|
+$39.7K |
| 4 |
VF
Virtu Financial
New York
|
+$29.8K |
| 5 |
BNP Paribas Financial Markets
Paris,
France
|
+$27.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
AIGH Capital Management
Baltimore,
Maryland
|
-$950K |
| 2 |
CWP
Cyndeo Wealth Partners
St. Petersburg,
Florida
|
-$163K |
| 3 |
FDCDDQ
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
|
-$84.9K |
| 4 |
NA
NewEdge Advisors
New Orleans,
Louisiana
|
-$49.2K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$28.3K |
THTX Hedge Fund Activity: Q4 2024 in Review
41 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Theratechnologies (THTX) for Q4 2024, worth a combined $25.2M — up 40% from $18M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new THTX positions and 3 closed out — a net gain of 5 holders — while 10 added to existing stakes and 7 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $81.4K. The largest seller was AIGH Capital Management, cutting an estimated $950K.
- 41 institutional investors held Theratechnologies (THTX) as of Q4 2024, up from 36 in Q3 2024.
- Funds reported $25.2M of Theratechnologies stock for Q4 2024, up 40% quarter-over-quarter.
- 8 funds opened new Theratechnologies positions in Q4 2024 and 3 closed out, a net change of +5 holders.
- The largest Theratechnologies buyer in Q4 2024 was Morgan Stanley, an estimated $81.4K added.
- The largest Theratechnologies seller in Q4 2024 was AIGH Capital Management, an estimated $950K sold.
Based on aggregated 13F filings for Q4 2024.